amylin analogue cagrilintide analog Cagrilintide Amylin Analog for Metabolic

Fosgonimeton is a phosphate prodrug of Dihexa developed by Athira Pharma (formerly M3 Biotechnology)

Brand names are used for informational purposes only

BPC-157 has demonstrated broad beneficial effects across preclinical models (tissue injury, inflammatory bowel disease, and central nervous system disorders), giving rise to its reputation as a multi-system repair compound, according to a review published in Pharmaceuticals

Not only do our bodies create and grow life, but they also change along the way commonly developing issues such as incontinence, constipation, pelvic pain, pelvic organ prolapse, diastasis recti and low back/hip/pelvic girdle pain

No obvious toxicity has been reported in rodent studies at effective doses